2016

Baran Y. Outcomes of Targeting BCR/ABL Tyrosine Kinase Protein for the Treatment of Chronic Myeloid Leukemia. Dünya Bilimler Akademisi, Senelik Genel Kurul Toplantısı, 12-16 Kasım 2016, Kigali, Ruanda Cumhuriyeti.

2016

Baran Y. Sphingolipid Metabolism and Signaling in the regulation of drug resistance in chronic myeloid leukemia. 4. Uluslararası İlaç Dizaynı Kongresi, 12-14 Ekim 2016, İstanbul, Türkiye

2016

Baran Y. Molecular Mechanisms of Drug Resistance in Hematological Malignancies. 16. Asya Bilim Konseyi, 30 Mayıs-2 Haziran 2016, Colombo, Sri Lanka.

2016

Baran Y. Sphingolipid Signaling in the Regulation of Drug Resistance in Chronic Myeloid Leukemia. Uluslararsı Genç Bilim İnsanları Konferansı ve Küresel Genç Akademi Senelik Genel Kurulu, 25-29 Mayıs 2016, Eindhoven, Hollanda.

2015

Kiraz Y, Adan A, Baran Y. Multidrug Resistance Mechanisms in Hematological Malignancies. TWAS Regional Office for Central & South Asia (TWAS-ROCASA), At: Jawaharlal Nehru Centre for Advanced Scientific Research, 21-22 Aralık 2015, Bangalure, Hindistan.

2015

Baran Y. Molecular Mechanisms of Drug Resistance in cancer. Dünya Bilimler Akademisi, Senelik Genel Kurul Toplantısı, 18-22 Kasım 2015, Viyana, Avustrya.

2015

Kiraz Y, Adan A, Baran Y. Multidrug Resistance Mechanisms in Leukemias. Uluslararsı Biyotıbbın Geleceği Kongresi, 2-7 Eylül 2015, Vladivastok, Rusya.

2015

Kacı N, Kiraz Y, Baran Y. Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Kiraz Y, Saydam G, SAhin F, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Avcu F, Ural AU, Unal A, Baran Y. Expression levels of Jak/STAT signaling genes in newly diagnosed drug sensitive and resistant chronic myeloid leukemia patients. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in ECC-1 endometrial cancer cells. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.

2015

Attar R, Cincin ZB, Bireller ES, Kiraz Y, Baran Y, Cakmakoglu B Investigation of potential anticarcinogenic effects by corilagin in SKOV-3 ovarian cell line carcinoma. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.

2015

Rencuzuoglu C, Cincin ZB, Kiraz Y, Baran Y, Cakmakoglu B. Investigation of potential anticarcinogenic effects by corilagin in lung cancer cells. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.

2015

Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Molecular mechanisms of quercitrin-induced apoptosis in ECC-1 endometrial cancer cell lines. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.

2015

Gokbulut Adan A, Baran Y. The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Gokbulut Adan A, Ogretmen B, Baran Y. Sphingosine-1-phosphate receptor 2/gq/phospholipase c axis is a novel mechanism to overcome nilotinib resistance in t315i mutation expressing 32dcl3 murine cells. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Gokbulut Adan A, Baran Y.  A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya

2015

Gokbulut Adan A, Ogretmen B, Baran Y. Overcoming nilotinib resistance by specific inhibition of sphingosine-1-phosphate receptor 2/gq/phospholipase c axis in chronic myeloid leukemia. Uluslararası Seramid Konferansı & Sfingolipid Kulüp Ortak Toplantısı, 6-10 Mayıs 2015, Çeşme, Türkiye.

2015

Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and  Acute Promyelocytic Leukemia Cells.  40. FEBS Kongresi, 2-4 Temmus 2015, Berlin, Almanya.

2015

Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and  Acute Promyelocytic Leukemia Cells. 40. FEBS Kongresi & Genç Bilim İnsanı Forumu, 2-4 Temmus 2015, Berlin, Almanya.

2015

Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Discovering Alternative Targets in Chronic Myeloid Leukemia (CML): Determination of Expression Levels of Bioactive Sphingolipid Genes in Newly Diagnosed and Drug-Resistant CML Patients. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Kartal Yandım M, Elmas E, Ceylan C, Baran Y. Antiproliferative and Apoptotic Effects of Ponatinib and its Effects on Macromolecular Changes in Imatinib-Sensitive and –Resistant Chronic Myeloid Leukemia (CML) Cell Lines: A Mechanistic Approach. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.

2015

Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Correlations Between Expression Levels of Bioactive Sphingolipid Genes and Drug-Ssensitivity and –Resistance in Chronic Myeloid Leukemia (CML) Patients. Uluslararası Seramid Konferansı & Sfingolipid Kulüp Ortak Toplantısı, 6-10 Mayıs 2015, Çeşme, Türkiye.

2014

Yandim MK, Baran Y. Cytotoxic and Cytostatic Effects of Ponatinib on Imatinib-Sensitive and -Resistant Chronic Myeloid Leukemia Cells. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye

2014

Kiraz Y, Neergheen-Bhujun V, Baran Y. Apoptotic Effects of Non-Edible Parts of Punica Granatum on Human Multiple Myeloma Cells. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye

2014

Kiraz Y, Yandim MK, Kozanoglu I, Ozdogu H, Piskin I, Ozcan M, Saydam G, Sahin F, Avcu F, Ural AU, Unal A, Baran Y. JAK/STAT Signaling Pathway Genes in the Regulation of Tyrosine Kinase Inhibitors Induced and Clinical Process in Chronic Myeloid Leukemia Patients. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye

2014

Koca D, Hastar N, Baran Y. Inhibition of Jumonji C Domain Containing Histone Demethylases in Acute Myeloid Leukemia. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye

2014

Gokbulut AA, Ogretmen B, Baran Y. Targeting Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptor 2signalling Pathway to Overcome T315i Mutation in 32dcl3 Cells. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye.

2014

Gokbulut AA, Baran Y. Cytotoxic and Apoptotic Effects of Fisetin, Hesperetin and Vitexinon Acute Promyelocytic Leukaemia Cells. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye.

2014

Gokbulut AA, Baran Y. Therapeutic Potential of Fisetin, Vitexin and Hesperetin on Chronic Myeloid Leukemia Cells. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye.

2014

Baran Y, Firatligil B, Yandim MK, Kiraz Y, Kozanoglu I, Ozdogu H, Piskin I, Ozcan M, Saydam G, Sahin F, Avcu F, Ural AUU, Unal A. A Novel Biomarker For Drug Resistance In Chronic Myeloid Leukemia: Microrna-17. 5. Uluslararası Avrasya Hematoloji Kongresi, 15-19 Ekim 2014, Antalya, Türkiye.

2014

Isik S, Karaman M, Baran Y, Kiray M, Caglayan-Sozmen S, Bagriyanik HA, Kozanoglu I, Gokbulut AA, Karaman O, Uzuner N. The effect of mezenchimal stem cells on lung and nasal histopathology and cytokin levels in a murine model of allergic rhinitis. Avrupa Akademisi Alerji ve Klinik İmmünoloji Kongresi, 7-11 Haziran 2014, Kopenhag, Danimarka.

2014

Kozanoglu I, Unver G, Sariturk C, Baran Y, Yeral M, Boga C, Ozdogu H. Comparison of Ishage-Based Cd34 (+) Cell Enumeratİon Protocols On Bd Facs Canto II And Attune Flow Cytometers. 40. Avrupa Kan ve Kemik İliği Transplantasyonu Derneği Kongresi, 30 Mart – 2 Nisan 2014, Milan, İtalya.

2013

Tufekci O, Yandim MK, Oren H, Irken G, Baran Y. Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia. 55. Amerika Hematoloji Derneği Kongresi,

7-10 December 2013, New Orleans, LA, USA.

2013

Avcı CB, Kayabasi C, Susluer SY, Balci T, Saydam G, Baran Y, Gunduz C. Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells. Avrupa Kanser Kongresi, 27 Eylül-1 Ekim 2013  Amsterdam, Hollanda.

2013

Kozanoglu I, Aygun B, Boga I, Cansun C, Oktar N, Maytalman E, Baran Y, Boga C, Ozdogu H. Immunologically Detection of Bcr/Abl Fusion Protein with Flow Cytometry in K562 Chronic Myeloid Leukemia Cellsand Comparison with RT-PCR Results. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2013

Katgı A, Gökbulut AA, Sevindik ÖG, Yüksel F, Solmaz SM, Özsan GH, Baran Y, Pişkin O. Effect of Nilotinib on the Function of Carotid Artery Endothelial Cells. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2013

Baran Y, Yandim MK, Kozanoglu I, Ozdoğu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Avcu F, Ural AU. Diagnostic and Therapeutic Potentials of Expression Levels of Bioactive Sphingolipid Genes in Newly Diagnosed and Drug-Resistant Chronic Myeloid Leukemia Patients. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2013

Baran Y, Yilmaz S, Cincin ZB, Cakmakoglu B, Kozanoglu I, Ozdogu H. Cytotoxic Effects of Apigenin on Multiple Myeloma Cells. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2013

Baran Y, Gokbulut AA, Solmaz A, Kozanoglu I, Ozdogu H. Effects of Apigenin on Imatinin-Sensitive And Resistant Chronic Myeloid Leukemia Cells. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç

2013

Baran Y, Gokbulut AA, Cincin ZB, Cakmakoglu B, Kozanoglu I. Changes in Gene Expression Profiles in Response to Apigenin in Imatinib Sensitive and Resistant Chronic Myeloid Leukemia Cells. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2013

Baran Y, İskender G, Piskin O, Ozcan MA. Determination of the Cytotoxic and Apoptotic Effects of Caffeic Acid Phenethyl Ester and Gossypol in Combination with Fludarabine at a Molecular Level in Acute Lymphoblastic Leukemia Cells. 18. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2013, Stokholm, İsveç.

2012

Kayabasi C, Avci CB, Susluer SY, Balci T, Baran Y, Saydam G, Gunduz C. Autophagic and Apoptotic Effects of Tyrosine Kinase Inhibitors in Myeloid Leukemia: Comparison of Three Generation. 54. Amerika Hematoloji Derneği Kongresi, 8-11 Aralık 2012 Atlanta, USA.

2012

Baran Y, Turan T, Sanlı-Mohamed G. Changes In Protein Profiles Of Multiple Myeloma Cells In Response To Bortezomib. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Saydam G, Kiper HD, Tezcanli B, Selvi N, Avci CB, Baran Y, Kosova B, Sahin F. Zoledronate Induces Apoptosis via Effecting on STAT Pathway in Chronic Myeloid Leukemia Cells. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Sahin F, Purclutepe O, Kiper HD, Tezcanli B, Selvi N, Avci CB, Baran Y, Kosova B, Saydam G, Enalapril Maleate has Cytotoxic Effect in HL60 Leukemic Cells By Altering STAT Signaling Pathway. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Baran Y, Gökbulut AA, Ozcan MA, Pişkin O, Unlü M. Antiproliferative And Apoptotic Effects Of Resveratrol On Chronic Lymphocytic Leukemia Cells. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Baran Y, Gökbulut AA, Apohan E, Pişkin O, Ozcan MA. Quercetın Induced Apoptosis In 232b4 Chronic Lymphocytic Leukemia Cells. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Baran Y, Gökbulut AA, Yasar M. A Novel Agent, KL-21, Has Significant Anticancer Potential On Chronic Lymphocytic Leukemia Cells But Not In Healthy Cells. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2012

Baran Y, Kartal M, Kozanoğlu İ. A Natural Product, Quercetin Enhances The Cytotoxic And Apoptotic Effects Of Dexamethasone On Jurkat Cells. 17. Avrupa Hematoloji Derneği Kongresi, 13-17 Haziran 2012, Amsterdam, Hollanda.

2011

Gökbulut AA, Kartal M, Yaşar M, Baran Y. A Promising New Anticancer Agent, KL-21, Inhibits Proliferation And Cell Cycle Progression And Induces Apoptosis In Chronic Lymphocytic Leukemia Cells But Has No Effect On Healthy Cells. EACR Anticancer Agents Research Congress. 13-16 Ekim 2011, Antalya, Türkiye.

2011

Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O. Mesenchymal Stem Cells Ameliorate The Histopathological Changes In A Murine Model Of Chronic Asthma. 30. Avrupa Akademisi Alerji ve Klinik İmmünoloji Kongresi, 11-15 Haziran 2011, İstanbul, Türkiye.

2011

Baran Y, Kozanoglu I, Kartal M, Ozdogu H, Sarıalioglu F. A new indication for an old drug; Therapeutic potential of propranolol on human multiple myeloma cells. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Gencer EB, Güçlüler G. Apoptotic Effects of Sunitinib on Multıple Myeloma Cells. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Camgoz A, Ceylan C. The roles of Macromolecules in Imatinib Resistance in Chronic Myeloid Leukemia. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Camgoz A, Ceylan C. Analyses Of Macromolecules In Nilotinib Resistance By Fourier Transform Infrared Spectroscopy. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Sunay O, Çakır Z, Can G, Denek Z, Kozanoğlu I, Yılmaz M. Therapeutic Potentials Of Mesenchymal Stem Cells In Bone Defects, The Case Study In Rabbit Tibia. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Cakir Z. Determination Of Cytotoxic Effects Of Gossypol On Multiple Myeloma Cells. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Cakir Z. Combination Of Resveratrol And Nilotinib Inhibits Cell Proliferation And Induce Apoptosis Synergistically In Chronic Myeloid Leukemia Cells. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2011

Baran Y, Camgoz A, Ural AU, Avcu F. Molecular Mechanisms Of Nilotinib Resistance And Reversal Of Resistance In Chronic Myeloid Leukemia Cells. 16. Avrupa Hematoloji Derneği Kongresi, 9-12 Haziran 2011, Londra, İngiltere.

2010

Baran Y, Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N. The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells. 21. Avrupa Kanser Araştırma Kongresi, 26-29 Haziran 2010, Oslo, Norveç.

2010

Cakır Z, Baran Y, Can G, Saydam G, Sahin F. Gene Expression Profiles in Resveratrol-Induced Cell Death in Acute Promyelocytic Leukemia Cells. 21. Avrupa Kanser Araştırma Kongresi, 26-29 Haziran 2010, Oslo, Norveç.

2010

Can G, Baran Y. Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells. 21. Avrupa Kanser Araştırma Kongresi, 26-29 Haziran 2010, Oslo, Norveç.

2010

Baran Y, Camgoz A, Can G. Changes in Expression Profiles of Apoptosis, Invasion, Metastasis, Angiogenesis, Transcription Factors, Cell Cycle Control and Tumor Supressor Genes in Nilotinib Treated Chronic Myeloid Leukemia Cells. 21. Avrupa Kanser Araştırma Kongresi, 26-29 Haziran 2010, Oslo, Norveç.

2010

Baran Y, Bassoy EY, Cakir Z, Camgoz A, Gencer EB, Kartal M, Can G, Ekiz HA, Gucluler G. Therapeutic Potential of Targeting Sphingolipid Signaling Pathways in Various Types of Cancers. 21. Avrupa Kanser Araştırma Kongresi, 26-29 Haziran 2010, Oslo, Norveç.

2010

Baran Y, Kartal M, Cakir Z, Saydam G, Sahin F. Ceramides Regulate Resveratrol-Induced Apoptosis In Human Acute Promyelocytic And Chronic Myeloid Leukemia Cells. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Baran Y, Camgoz A, Gencer EB, Ural AU, Avcu F. A Novel Mechanism Of Nilotinib-Induced Apoptosis; Bioactive Sphingolipids. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Baran Y, Cakir Z, Can G, Saydam G, Sahin F. Gene Expression Profiles In Resveratrol Applied Acute Promyelocytic Leukemia Cells. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya

2010

Baran Y, Kartal M, Can G. Molecular Mechanisms of Resveratrol-Induced Cell Death in K562 Chronic Myeloid Leukemia Cells. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Baran Y, Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N. Suppression of STAT5a Increases Chemotherapeutic Sensitivity in Imatinib-Resistant and Imatinib-Sensitive K562 Cells. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Baran Y, Zincir S, Çakır Z, Ozturk E, Topçu Z. Imatinib-İnduced Apoptosis; A Possible Link To Topoisomerase Enzyme Inhibition. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Baran Y, Camgoz A, Can G. Expression Analysis Of 84 Genes Involved In Different Signalling Pathways Of Cancer In Chronic Myeloid Leukemia Cells In Response To Nilotinib. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2010

Can G, Baran Y. Apoptotic Effects Of Resveratrol On Imatinib Sensitive and Resistant Chronic Myeloid Leukemia Cells. 15. Avrupa Hematoloji Kongresi, 10-13 Haziran 2010, Barselona, İspanya.

2009

Goktas S, Ural AU, Baran Y, Yazici S, Aydur E, Avcu F, Pekel A, Dirican B. Beyzadeoglu, M. Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity In Androgen Independent Human Prostate Cancer Cells. 104. Amerikan Ürolojik Derneği Toplantısı, 25-30 Nisan 2009, Chicago, IL, ABD.

2009

Çakır Z, Saydam G, Şahin F, Baran Y. Resveratrol Induces Apoptosis Through Induction of Accumulation of Ceramides in Human HL-60 Acute Promyelocytic Cells. Lipid Sinyali ve Hastalıkları Kongresi (Lipid Signalling and Diseases Congress), 9-15 Eylül 2009, Ortona, İtalya, S:40.

2009

Baran Y, Güçlüler G. Anticancer Agents Used for the Treatment of Breast Cancer Induces Apoptosis Through Downregulating Antiapoptotic Sphingosine Kinase-1 and Glucosylceramide Synthase Genes in MCF-7 Cells. Lipid Sinyali ve Hastalıkları Kongresi (Lipid Signalling and Diseases Congress), 9-15 Eylül 2009, Ortona, İtalya, S:38-39.

2009

Gencer EB, Ural AU, Avcu F, Baran Y. Dasatinib induces apoptosis through increasing de novo generation or accumulation of ceramides in human K562 and Meg-01 chronic myeloid leukemia cells. Lipid Sinyali ve Hastalıkları Kongresi (Lipid Signalling and Diseases Congress), 9-15 Eylül 2009, Ortona, İtalya, S:46.

2009

Baran Y, Can G, Ekiz A. Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells, as Effectively as in Parental Sensitive Counterparts. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association,) 04-07 Haziran 2009, Berlin, Almanya, S:343.

2009

Baran Y, Can G, Ekiz A, Genç Ş. Imatinib Induces Autophagy Through Increasing The Expression Levels of Beclin-1 And ATG-5 Genes in Both Parental Sensitive and Imatinib-Resistant K562 Cells. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:233.

2009

Kartal M, Saydam G, Şahin F, Baran Y. Increasing Intracellular Generation or Accumulation of Ceramides Increased Cytotoxic Effects of Resveratrol in Human K562 Chronic Myeloid Leukemia Cells. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:497.

2009

Çakır Z, Saydam G, Şahin F, Baran Y. The Effects of Ceramide, Glucosylceramide and Sphingosine 1 Phosphate in Resveratrol Induced Cell Death in HL60 Acute Promyelocytic Leukemia Cells. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:540-541.

2009

Baran Y, Gencer EB, Ural AU, Avcu F. Increasing De Novo Synthesis of Ceramides Increased Nilotinib Induced Apoptosis in Human Meg-01 Chronic Megacaryoblastic Cells. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:569.

2009

Gencer EB, Ural AU, Avcu F, Baran Y. Targeting Ceramide Metabolism Increased Sensitivity of Philadelphia Positive Chronic Megacaryoblastic Leukemia Cells to Dasatinib. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:132.

2009

Baran Y, Gencer EB, Ural AU, Avcu F. Accumulation of Apoptotic Ceramides Increased Apoptotic Effects of Nilotinib in Philadelphia Positive Meg-01 Cells Synergistically. 14. Avrupa Hematoloji Derneği Kongresi (14th Congress of European Hematology Association), 04-07 Haziran 2009, Berlin, Almanya, S:570.

2009

Deveci D, Yüce H, Baran Y. A case Report with Trisomy 8 Mosaicism. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:30.

2009

Baran Y, Bassoy EY, Cakir Z. Inhibition of Conversion of Apoptotic Sphingosine Molecule to Antiapoptotic Sphingosine-1-Phosphate Increased Sensitivity of Prostate Cancer Cells to Docetaxel. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:110.

2009

Baran Y, and Güçlüler G. The Role of Sphingosine Kinase-1 Which Converts Apoptotic Sphingosine to Antiapoptotic Sphingosine-1-Phosphate in Docetaxel, Paclitaxel, Doxorubicin, Cyclophosphamide and Tamoxifen Induced Apoptosis in MCF-7 Breast Cancer Cells. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:110.

2009

Bassoy EY, Kartal M, Baran Y. The Involvement of Glucosyle Ceramide Synthase in Docetaxel-Induced Apoptosis in Human DU-145 and PC-3 Prostate Cancer Cells. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:108-109.

2009

Bassoy EY, Gencer EB, Baran Y. The role of LASS1 gene and ceramide accumulation in docetaxel-induced apoptosis in hormone resistant DU-145 and PC-3 Prostate Cancer Cells. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:111.

2009

Baran Y, Güçlüler G. The Involvement of Glucosyle Ceramide Synthase Gene on Induction of Apoptosis in Response to Different Anticancer Agents in MCF-7 Breast Cancer Cells. 8. Balkan İnsan Genetiği Kongresi (8th Balkan Meeting On Human Genetics), 14-17 Mayıs 2009, Dubrovnik, Hırvatistan, S:104.

2008

Durcan C, Seher G, Bassoy EY, Can G, Baran Y. Combination of Fludarabine and Imatinib-Induced Apoptosis Through Loss of Mitochondrial Membrane Potential and Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells. 32. Uluslararası Dünya Hematoloji Derneği Kongresi (32nd World Congress of International Society of Hematology), 19-23 Ekim 2008, Bangkok, Tayland, S:33.

2008

Durcan C, Ural AU, Avcu F, Baran Y. Targeting Conversion of Apoptotic Ceramide to Antiapoptotic Glucosyle Ceramide Increased Cytotoxic Effects of Nilotinib in Ph(+) Human Chronic Myeloid Leukemia Cells. 32. Uluslararası Dünya Hematoloji Derneği Kongresi (32nd World Congress of International Society of Hematology), 19-23 Ekim 2008, Bangkok, Tayland, S:109.

2008

Bassoy EY, Ozcimen B, Durcan C, Can G, Yusuf B. Inhibition of Proteasome by Bortezomib Increased Chemosensitivity of BCR/ABL Positive K562 Human Chronic Myleoid Leukemia Cells to Imatinib. Uluslararası Dünya Hematoloji Derneği Kongresi (32nd World Congress of International Society of Hematology), 19-23 Ekim 2008, Bangkok, Tayland, S:108.

2008

Durcan C, Ugur AU, Ferit A, Baran Y. Inhibition of Ceramide Turnover by Glucosyle Ceramide Inhibitor, PDMP, Increased Dasatinib-Induced Apoptosis. 32. Uluslararası Dünya Hematoloji Derneği Kongresi (32nd World Congress of International Society of Hematology), 19-23 Ekim 2008, Bangkok, Tayland, S:108.

2008

Gucluler G, and Baran Y. Docetaxel Enhances The Cytotoxic Effects of Imatinib in Philadelphia Positive Human Chronic Myeloid Leukemia Cells. 32. Uluslararası Dünya Hematoloji Derneği Kongresi (32nd World Congress of International Society of Hematology), 19-23 Ekim 2008, Bangkok, Tayland, S:32.

2008

Avcu F, Ural AU, Sarper M, Uyuklu T, Baran Y, Safali M, Elçi P. The effects of proteasome inhibitor bortezomib on osteoblast differentiation of human bone marrow derived multipotent mesenchymal stem cells, In vitro. 14. Uluslararası Hücresel Tedavi Derneği Kongresi (14th Annual International Society for Cellular Therapy Meeting), 17-20 Mayıs 2008, Miami, Florida, Amerika Birleşik Devletleri, S: 55.

2008

Uyuklu T, Ural AU, Sarper M, Avcu F, Baran Y, Elci P, Akar N. A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines In Vitro. 49. Amerika Hematoloji Derneği Kongresi (The 49th American Society of Hematology Annual Meeting and Exposition), 8-11 Aralık 2007, Georgia, Atlanta, Amerika Birleşik Devletleri, S:113.

2007

Uyuklu T, Ural AU, Sarper M, Avcu F, Baran Y, Elci P, Akar N. A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines In Vitro. 49. Amerika Hematoloji Derneği Kongresi (The 49th American Society of Hematology Annual Meeting and Exposition), 8-11 Aralık 2007, Georgia, Atlanta, Amerika Birleşik Devletleri, S:113.

2006

Baran Y, Salas A, Şenkal CE, Bielawski J, Gündüz U, Obeid LM, Öğretmen B. Alterations of human longevity assurance gene1 (LASS1)/Sphingosine Kinase-1-dependent ceramide generation and metabolism involve in the regulation of imatinib-induced apoptosis and resistance in K562 human chronic myeloid leukemia. 41. Güneydoğu Bölgesel Lipid Konferansı (The 41st South Eastern Regional Lipid Conference), 1-3 Kasım 2006, Cashiers, North Carolina, Amerika Birleşik Devletleri, S:50.

2006

Baran Y, Gündüz U, Öğretmen B. The sequence analyses of imatinib mesylate binding site of ABL kinase domain in sensitive and imatinib-resistant human CML cells. 7. Balkan İnsan Genetiği Kongresi (7th Balkan Meeting on Human Genetics), 31 Ağustos- 2 Eylül 2006, Üsküp, Makedonya Cumhuriyeti, S:128.

2006

Baran Y, Gündüz U, Bielawski J, Öğretmen B. Circumventing multidrug resistance by a combination therapy of imatinib and GCS inhibitor in resistant human chronic myeloid leukemia cells. 7. Balkan İnsan Genetiği Kongresi (7th Balkan Meeting on Human Genetics), 31 Ağustos- 2 Eylül 2006, Üsküp, Makedonya Cumhuriyeti, S:127.

2006

Baran Y, Gündüz U, Ural AU, Öğretmen B. Apoptotic pathways induced by imatinib in sensitive and imatinib-resistant K562 cells. 7. Balkan İnsan Genetiği Kongresi (7th Balkan Meeting on Human Genetics), 31 Ağustos- 2 Eylül 2006, Üsküp, Makedonya Cumhuriyeti, S:127.

2006

Baran Y, Gündüz U, Şenkal BE, Bielawski J, Öğretmen B. The involvement of ceramides in imatinib induced apoptosis and drug resistance. 7. Balkan İnsan Genetiği Kongresi (7th Balkan Meeting on Human Genetics), 31 Ağustos- 2 Eylül 2006, Üsküp, Makedonya Cumhuriyeti, S:44.

2006

Baran Y, Ural AU, Öğretmen B, Gündüz U. Multidrug resistance mechanisms in human chronic myeloid leukemia cells. 11. Avrupa Hematoloji Derneği Kongresi (11th Congress of European Hematology Association), 15-18 Haziran 2006, Amsterdam, Hollanda, S:16.

2006

Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. The involvement of C:18 ceramide and human longevity assurance genes in imatinib induced apoptosis. 11. Avrupa Hematoloji Derneği Kongresi (11th Congress of European Hematology Association), 15-18 Haziran 2006, Amsterdam, Hollanda, S:124.

2006

Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. Ceramide glycosylation by glucosylceramide synthase inhibits the apoptotic effect of imatinib on human K562 and Meg-01 cells. 11. Avrupa Hematoloji Derneği Kongresi (11th Congress of European Hematology Association), 15-18 Haziran 2006, Amsterdam, Hollanda, S:125.

2006

Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. Overcoming the chemoresistance in human chronic myeloid leukemia K562 cells by siRNA inhibition of sphingosine kinase-1. 11. Avrupa Hematoloji Derneği Kongresi (11th Congress of European Hematology Association), 15-18 Haziran 2006, Amsterdam, Hollanda, S:15.

2005

Avcu F, Ural AU, Baran Y, Sobacı G, Deveci M, Çetin A, Pekel A, Sarper M, Elçi P, Gündüz U. A photodynamic pathway to apoptosis induced by hypericin in human myeloma ARH-77 cell line: Possible relevance to photodynamic therapy. 47. Amerika Hematoloji Derneği Kongresi, 10-13 Aralık 2005, Amerika Birleşik Devletleri, S:351B.

2004

Baran Y, Gündüz U, Ural AU. Investigations of cross-resistance to cytarabine in human promyelocytic leukemia cell line selected for resistance to Vincristine. 6. Balkan İnsan Genetiği Kongresi (6th Balkan Meeting on Human Genetics), 28-31 Ağustos 2004, Selanik, Yunanistan, S:66.

2005

Kars DM, İşeri DÖ, Atalay C, Baran Y, Kaya P, Gündüz U. Investigation of molecular mechanisms of multiple drug resistance in different cell lines and tissue types. Avrupa COST Aksiyonu, B16 Çoklu İlaç Dirençliliğinin Geri Çevrilmesi Sempozyumu (The European COST action B16 Symposium on Multidrug Resistance Reversal), 13-14 Mayıs 2005, Antalya, Türkiye, S:35.